HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRELSTAR safely and effectively. See full prescribing information for TRELSTAR. TRELSTAR® (triptorelin pamoate for

First Page		Document Content
Date: 2014-07-15 09:54:17 GnRH agonists Fertility medicine Gonadotropin-releasing hormone agonist Testosterone Triptorelin Diabetes management Prostate cancer Gonadotropin-releasing hormone antagonist Leuprorelin Endocrine system Medicine Endocrinology		HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRELSTAR safely and effectively. See full prescribing information for TRELSTAR. TRELSTAR® (triptorelin pamoate for Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 421,75 KB Share Document on Facebook

	Microsoft Word - DSU Degarelix FINAL sent to NICE DocID: 1oZJA - View Document
	16 SeptemberProhibited List Summary of Major Modifications and Explanatory Notes SUBSTANCES AND METHODS PROHIBITED AT ALL TIMES (IN- AND OUT-OFCOMPETITION) PROHIBITED SUBSTANCES DocID: 1nvS9 - View Document
	Kwartaalbericht 3e kwartaaldecember 2002 Contents DocID: 15NH9 - View Document
	State of Vermont Department of Vermont Health Access 312 Hurricane Lane, Suite 201 Williston, VTwww.dvha.vermont.gov DocID: 13avT - View Document
	Public Summary Document – November 2014 PBAC Meeting 6.7 LEUPRORELIN 30 mg injection: modified release [1 x 30 mg syringe] (&) DocID: 12zdb - View Document